Keep reading for just $1
$1 trial for two weeks, thereafter $8.50 every two months, cancel any time
Signed in as . Sign out
A DNA test has been developed to screen patients for a range of neurological and neuromuscular genetic diseases quicker and more accurately than existing tests. The technology is able to identify over 50 hard-to-diagnose diseases, including Huntington's disease, muscular dystrophies and fragile X syndrome. It's hoped the test will end the 'diagnostic odyssey' for patients, which can sometimes take decades.
A DNA test has been developed to screen patients for a range of neurological and neuromuscular genetic diseases quicker and more accurately than existing tests.
The technology is able to identify over 50 hard-to-diagnose diseases, including Huntington’s disease, muscular dystrophies and fragile X syndrome.
It’s hoped the test will end the ‘diagnostic odyssey’ for patients, which can sometimes take decades.
Subscribe to our free newsletter for news and prizes
3
$1 trial for two weeks, thereafter $8.50 every two months, cancel any time
Signed in as . Sign out